This Biotech Used CAR-T To Cure Someone With Acute Myeloid Leukemia
Subscribe now for the coolest biotech interviews! https://www.youtube.com/channe....l/UCLOWmW12tA2dYsPLg
Description: For our Brussels edition of Refresh, sponsored by NIBC and Scientist.com, Philip Hemme chatted to Christian Homsey, CEO of Celyad, to discuss the new generation of CAR-T for oncology and how this gave them positive Phase 1 results and cured someone with acute myeloid leukemia.
About Labiotech.eu:
Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!
Facebook: https://www.facebook.com/Labiotech.eu
Twitter: https://twitter.com/Labiotech_eu
Linkedin: https://www.linkedin.com/company/labiotech-eu/
Instagram: https://www.instagram.com/labiotech.eu
-
Category
No comments found